+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recent advances and novel agents for gastrointestinal stromal tumor GIST



Recent advances and novel agents for gastrointestinal stromal tumor GIST



Journal of Hematology & Oncology 5(1): 21



The discovery of CD117 mutation in almost all gastrointestinal stromal tumors (GISTs) marked a milestone. Other spindle cell neoplasms arising from the GI tract including lipoma, schwannoma, hemangioma, leiomyoma, and leiomyosarcoma are typically CD117-negative. GIST research and clinical care now represent a paradigm of translating discoveries in the molecular pathogenesis of cancer into highly effective targeted therapies that selectively inhibit etiologic driver pathways, leading to dramatically improved clinical outcomes. A series of investigations and trials are underway to develop novel and effective ways to treat patients with GIST. In this review, we discuss the highlights of recent advances and novel agents for GIST therapy.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 036527323

Download citation: RISBibTeXText


Related references

Recent advances and novel agents for gastrointestinal stromal tumor (GIST). Journal of Hematology & Oncology 5: 21-21, 2012

Recent advances and novel agents forgastrointestinal stromal tumor GIST. 2012

Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST). Cancer Biology and Therapy 3(3): 251-258, 2004

Gastrointestinal stromal tumor (GIST): advances in 2013. Ceskoslovenska Patologie 50(2): 76-80, 2014

Clinical pathology of gastrointestinal stromal tumor (GIST): With special reference to change of the cencept of gastrointestinal mesenchymal tumor (GIMT) and the definition and organ specificity of GIST. Stomach and Intestine 36(9): 1113-1127, 2001

Recent progress in gastrointestinal stromal tumor (GIST). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(9): 1495-1501, 2002

Is gastrointestinal stromal tumor (GIST) originating from the rectovaginal septum GIST or extra-GIST (EGIST)? A case report with literature review. European Journal of Gynaecological Oncology 36(6): 750-754, 2015

Recent Advances in Cell Biology, Diagnosis and Therapy of Gastrointestinal Stroma Tumor (GIST). Cancer Biology & Therapy 3(3): 251-258, 2004

Gastrointestinal stromal tumor (GIST) pathogenesis, familial GIST, and animal models. Seminars in Diagnostic Pathology 23(2): 63-69, 2006

When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis. World Journal of Surgical Oncology 7: 8, 2009

Coexistence of gastrointestinal stromal tumor (GIST) of the rectum and adenocarcinoma of the prostate in a patient with familial GIST. Onkologie 31(12): 697-699, 2008

Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China. Medicine 96(46): E8240, 2017

Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cells. Plos one 9(9): E107613, 2014

The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents. Acta Radiologica 54(7): 711-721, 2013

Recent advances in managing gastrointestinal stromal tumor. F1000research 6: 1689, 2017